Elite Pharmaceuticals Market Cap

Elite Pharmaceuticals has a market cap or net worth of $742.59 million as of September 26, 2025. Its market cap has increased by 76.92% in one year.

Market Cap

742.59M

Enterprise Value

727.53M

Revenue

105.45M

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.69

Market Cap Chart

Since July 23, 1998, Elite Pharmaceuticals's market cap has increased from 9.58M to 742.59M, an increase of 7,655.33%. That is a compound annual growth rate of 17.35%.

Market Cap History

Date	Market Cap	% Change
Sep 26, 2025	742.59M	28.47%
Dec 31, 2024	578.04M	306.60%
Dec 29, 2023	142.16M	374.74%
Dec 30, 2022	29.95M	-10.40%
Dec 31, 2021	33.42M	-36.49%
Dec 31, 2020	52.63M	-31.72%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Veradigm	789.71M
Tian'an Technology Group	718.73M
Glass House Brands	516.60M
Northwest Biotherapeutics	387.17M
CytoDyn	332.57M
American Oncology Network	305.31M
Nika Pharmaceuticals	301.74M
Silence Therapeutics	261.68M

Market Cap Rankings